1. Metabolic Enzyme/Protease
  2. Phosphodiesterase (PDE)
  3. PDE5-IN-1

PDE5-IN-1 (compound 2) 是一种 PDE5 抑制剂,其 IC50 为 5.6 nM,且具备口服生物利用度。PDE5-IN-1 可与 PDE5 催化结构域中的 Q817 残基形成氢键相互作用,与 F820 残基形成芳香族 π-π 堆积相互作用。PDE5-IN-1 具有抗心肌肥厚和血管舒张作用,可降低平均肺动脉压及右心室肥厚指数。PDE5-IN-1 可用于肺动脉高压的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

PDE5-IN-1

PDE5-IN-1 Chemical Structure

CAS No. : 2109805-65-2

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PDE5-IN-1 (compound 2) is a PDE5 inhibitor with an IC50 of 5.6 nM and oral bioavailability. PDE5-IN-1 forms hydrogen bond interactions with the Q817 residue in the catalytic domain of PDE5, and aromatic π-π stacking interactions with the F820 residue. PDE5-IN-1 exerts anti-cardiac hypertrophy and vasodilatory effects, reduces mean pulmonary arterial pressure and right ventricular hypertrophy index. PDE5-IN-1 can be used in the research of pulmonary arterial hypertension[1].

体外研究
(In Vitro)

PDE5-IN-1 (compound 2) (多浓度;孵育 15 min) 可强效抑制 PDE5A 催化结构域,其 IC50 为 5.6 nM[1]
PDE5-IN-1 (多浓度;15 分钟) 对 PDE5A 表现出相较于其他 PDE 家族的显著选择性,选择性指数范围为 10 (相对于 PDE6A) 至>1700 (相对于 PDE1B、PDE3A、PDE7A1、PDE9A2)[1]
PDE5-IN-1 (多浓度) 对人类主要肝脏 CYP 同工酶仅具有微弱的抑制作用,其中仅对 CYP1A2 有中度抑制作用 (IC50 = 7.6 μM),而对其他六种关键同工酶无显著抑制作用[1]
PDE5-IN-1 (多浓度) 对 hERG 钾通道表现出弱抑制作用,其 IC50 >10 μM[1]
PDE5-IN-1 (0.5 μM; incubated to determine T1/2) 在大鼠和人肝微粒体中均稳定,其半衰期显著长于阳性对照咪达唑仑[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

药代动力学
(Parmacokinetics)
Species Dose Route T1/2 Cmax AUC0-t AUC0-∞ MRT0-t Tmax Bioavailability
Rat[1] 5 mg/kg p.o. 5.17 h 368 ng/mL 1997 ng·h/mL 2031 ng·h/mL 4.76 h 4.00 h 63.4 %
Rat[1] 2.5 mg/kg i.v. 6.02 h 2359 ng/mL 1703 ng·h/mL 1732 ng·h/mL 2.14 h / /
体内研究
(In Vivo)

PDE5-IN-1 (compound 2) (5.0 mg/kg,灌胃,每日 1 次,连续 3 周) 可在野百合碱 (MCT) 诱导的肺动脉高压 (PAH) 大鼠中显著降低 mPAP 和 RVHI,且其疗效优于 10.0 mg/kg 的枸橼酸西地那非[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Wister rats (8 weeks old, 180-220 g, MCT-induced PAH)[1]
Dosage: 5.0 mg/kg
Administration: p.o.; daily; 3 weeks
Result: Reduced mean pulmonary artery pressure (mPAP) to 18.65 mmHg, a statistically significant decrease compared to the PAH model group's 32.74 mmHg.
Reduced right ventricle hypertrophy index (RVHI) to a statistically significant level compared to the model group.
Exhibited better effects on both mPAP and RVHI than sildenafil citrate at 10.0 mg/kg.
分子量

402.42

Formula

C22H14N2O4S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
PDE5-IN-1
目录号:
HY-103084
需求量: